These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 2460667)

  • 1. [Experience with the combined use of 1st- and 2d-group anti-arrhythmic preparations in patients with refractory arrhythmia].
    Abdalla A; Mazur NA
    Klin Med (Mosk); 1988 Jun; 66(6):40-3. PubMed ID: 2460667
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effectiveness of a combination of mexitil with etmozin, allapinin or quinidine in ventricular extrasystole].
    Abdalla A; Mazur NA
    Klin Med (Mosk); 1988 May; 66(5):57-60. PubMed ID: 2458502
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experience in using anti-arrhythmia preparations of groups I and III in patients with arrhythmia resistant to therapy].
    Abdalla A; Mazur NA
    Kardiologiia; 1988 Mar; 28(3):51-4. PubMed ID: 2454343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term use of ethacizin in outpatients with ventricular disorders of heart rhythm].
    Shugushev KhKh; Rozenshtraukh LV; Smetnev AS; Ponamarenko EL
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):16-20. PubMed ID: 2432906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative study of the effectiveness of allapinin in patients with frequent and stable extrasystole].
    Abdalla A; Mazur NA; Sumarokov AB; Iavorskaia NV
    Kardiologiia; 1988 Nov; 28(11):95-7. PubMed ID: 2466144
    [No Abstract]   [Full Text] [Related]  

  • 6. [Potentiation of an anti-arrhythmia action by the combined use of mexiletine and propranolol].
    Pacholke H; Beck OA; Hochrein H
    Dtsch Med Wochenschr; 1984 Mar; 109(9):330-4. PubMed ID: 6199177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-arrhythmic effect of competitive aldosterone antagonists].
    Merzon AK; Khorunzhaia LV; Doviner AD; Berezov VM
    Vrach Delo; 1984 Apr; (4):18-22. PubMed ID: 6204456
    [No Abstract]   [Full Text] [Related]  

  • 8. [Optimization of the use of etmozin in treating patients suffering from frequent ventricular extrasystole].
    Bugriĭ EM; Mazur NA; Pavlova TS; Dzhishambaev ED
    Ter Arkh; 1986; 58(6):62-5. PubMed ID: 2429379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacodynamics and the pharmacokinetic parameters of etmozin in ventricular heart rhythm disorders].
    Kurbanov RD; Mazur NA; Piotrovskiĭ VK
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982; 5(2):55-8. PubMed ID: 6182893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Méxiletine. Action on heart rhythm disorders].
    Lellouche D; Bougherbal R
    Nouv Presse Med; 1975 Feb; 4(5):351-2. PubMed ID: 1093125
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical studies of Norpace (Part XI).
    Nisbet T
    Angiology; 1975 Jan; 26(1 Pt 2):149-53. PubMed ID: 46729
    [No Abstract]   [Full Text] [Related]  

  • 12. [Combination therapy with anti-arrhythmia agents].
    Kettner W; Götze C
    Z Arztl Fortbild (Jena); 1986; 80(21):889-92. PubMed ID: 2436386
    [No Abstract]   [Full Text] [Related]  

  • 13. Combination therapy with mexiletine and sotalol suppresses inherited ventricular arrhythmias in German shepherd dogs better than mexiletine or sotalol monotherapy: a randomized cross-over study.
    Gelzer AR; Kraus MS; Rishniw M; Hemsley SA; Moïse NS
    J Vet Cardiol; 2010 Aug; 12(2):93-106. PubMed ID: 20663731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy of arrhythmia induced by myocardial ischemia. Association of L-carnitine, propafenone and mexiletine].
    Mondillo S; Faglia S; D'Aprile N; Mangiacotti L; Campolo MA; Agricola E; Palazzuoli V
    Clin Ter; 1995 Dec; 146(12):769-74. PubMed ID: 8681496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combination anti-arrhythmia therapy].
    Manz M; Jung W; Lüderitz B
    Internist (Berl); 1993 May; 34(5):444-51. PubMed ID: 7685329
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effectiveness of mexiletine in arrhythmia of effort].
    Zacà F; Cremonesi A; Pagliarani PL; Guelfi P; Bugiardini R; Lasagna I; Ghinelli M; Luciani G
    Minerva Cardioangiol; 1981 Nov; 29(11):655-60. PubMed ID: 6173818
    [No Abstract]   [Full Text] [Related]  

  • 17. Dose effect of moricizine on suppression of ventricular arrhythmias.
    Morganroth J
    Am J Cardiol; 1990 Feb; 65(8):26D-31D; discussion 68D-71D. PubMed ID: 1689534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Membrane-stabilizing preparations in the treatment of patients with heart rhythm disorders of different etiologies].
    Vizir AD; Grigor'eva ZE; Stepanova IV; Vizir VA
    Vrach Delo; 1991 Oct; (10):32-6. PubMed ID: 1803742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results of the clinical study of a new anti-arrhythmia preparation allapinin].
    Mazur NA; Ivanova LA; Pavlova TS
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):30-3. PubMed ID: 3541962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Double-blind research on the anti-arrhythmia effect of ethacizin].
    Gorbachev VV; Pristrom MS; Sytyĭ VP; Mrochek AG; Odinets VS
    Klin Med (Mosk); 1986 Apr; 64(4):41-5. PubMed ID: 3523032
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.